Tumor necrosis factor-α inhibitor-related autoimmune disorders
L De Stefano, FB Pallavicini, E Mauric, V Piccin… - Autoimmunity …, 2023 - Elsevier
Biotechnological monoclonal antibodies and receptor antagonists capable of targeting
specific inflammatory actors, such as cytokines, cytokines receptors, co-stimulatory …
specific inflammatory actors, such as cytokines, cytokines receptors, co-stimulatory …
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of …
A Sepriano, A Kerschbaumer, SA Bergstra… - Annals of the …, 2023 - ard.bmj.com
Objectives To perform a systematic literature review (SLR) concerning the safety of synthetic
(s) and biological (b) disease-modifying antirheumatic drugs (DMARDs) to inform the 2022 …
(s) and biological (b) disease-modifying antirheumatic drugs (DMARDs) to inform the 2022 …
Venous thromboembolism in rheumatoid arthritis: the added effect of disease activity to traditional risk factors
MA Omair, SA Alkhelb, SE Ezzat… - Open Access …, 2022 - Taylor & Francis
Many epidemiological studies have shown an increased risk of venous thromboembolism
(VTE) in patients with rheumatoid arthritis (RA). RA and VTE share some background …
(VTE) in patients with rheumatoid arthritis (RA). RA and VTE share some background …
Venous thromboembolism in the inflammatory rheumatic diseases
Venous thromboembolism (VTE), which generally refers to either deep venous thrombosis
(DVT) or pulmonary embolism (PE), is an important cardiovascular comorbidity in chronic …
(DVT) or pulmonary embolism (PE), is an important cardiovascular comorbidity in chronic …
A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis
R Sen, M Riofrio, JA Singh - Expert Opinion on Drug Safety, 2024 - Taylor & Francis
Introduction Disease-modifying anti-rheumatic drugs (DMARDs) have improved the
outcomes of patients with rheumatoid arthritis (RA). DMARDs are classified into three …
outcomes of patients with rheumatoid arthritis (RA). DMARDs are classified into three …
[HTML][HTML] The impact of bDMARDs on postoperative complications in patients with rheumatoid arthritis: A systematic review and meta-analysis
T Suto, K Okamura, H Sakane, C Okura, T Kaneko… - Medicine, 2023 - journals.lww.com
Background: The influence of biological disease-modifying antirheumatic drugs (bDMARDs)
on postoperative surgical site infection (SSI) and venous thromboembolism (VTE) in patients …
on postoperative surgical site infection (SSI) and venous thromboembolism (VTE) in patients …
[HTML][HTML] The Impact of Visual Impairment on Healthcare Use among Four Medical Institution Types: A Nationwide Retrospective Cohort Study in Korea
Purpose The aim of this study was to determine the effect of visual impairment (VI) onset on
the use of healthcare services across four types of institutions in South Korea. Materials and …
the use of healthcare services across four types of institutions in South Korea. Materials and …